A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation

por Hills, Thomas, Jakeman, Phillip G., Carlisle, Robert C., Klenerman, Paul, Seymour, Leonard W., Cawood, Ryan
Publicado 2016

Quantification of ultrasonic texture intra-heterogeneity via volumetric stochastic modeling for tissue characterization

por Al-Kadi, Omar S., Chung, Daniel Y.F., Carlisle, Robert C., Coussios, Constantin C., Noble, J. Alison
Publicado 2015

Active Adenoviral Vascular Penetration by Targeted Formation of Heterocellular Endothelial–epithelial Syncytia

por Chen, Hannah H, Cawood, Ryan, El-Sherbini, Yasser, Purdie, Laura, Bazan-Peregrino, Miriam, Seymour, Leonard W, Carlisle, Robert C
Publicado 2011

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine

por Weissmueller, Nikolas T., Marsay, Leanne, Schiffter, Heiko A., Carlisle, Robert C., Rollier, Christine S., Prud’homme, Robert K., Pollard, Andrew J.
Publicado 2017

Ultrasound-Propelled Nanocups for Drug Delivery

por Kwan, James J, Myers, Rachel, Coviello, Christian M, Graham, Susan M, Shah, Apurva R, Stride, Eleanor, Carlisle, Robert C, Coussios, Constantin C
Publicado 2015

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation

por Skaripa-Koukelli, Irini, Hauton, David, Walsby-Tickle, John, Thomas, Eloïse, Owen, Joshua, Lakshminarayanan, Abirami, Able, Sarah, McCullagh, James, Carlisle, Robert C., Vallis, Katherine A.
Publicado 2021

Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides

por Bavelaar, Bas M., Song, Lei, Jackson, Mark R., Able, Sarah, Tietz, Ole, Skaripa-Koukelli, Irini, Waghorn, Philip A., Gill, Martin R., Carlisle, Robert C., Tarsounas, Madalena, Vallis, Katherine A.
Publicado 2021

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

por Carlisle, Robert C., Di, Ying, Cerny, Anna M., Sonnen, Andreas F.-P., Sim, Robert B., Green, Nicola K., Subr, Vladimir, Ulbrich, Karel, Gilbert, Robert J. C., Fisher, Kerry D., Finberg, Robert W., Seymour, Leonard W.
Publicado 2009